Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q1 EPS of ($0.32), $0.37 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $251.15 million.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.